PPL
65
6
VLO
40
-5
DOV
64
-5
ACN
56
13
TSN
31
-4
ESS
60
-8
IVZ
50
-3
FMC
40
4
EBAY
47
-2
SCHW
52
3
MDLZ
65
-2
NTAP
60
2
NSC
62
-5
VNO
57
-2
T
56
2
TRIP
66
5
BRK.B
42
-3
SYF
65
-6
CF
57
-3
SBUX
41
-3
PPL
65
6
VLO
40
-5
DOV
64
-5
ACN
56
13
TSN
31
-4
ESS
60
-8
IVZ
50
-3
FMC
40
4
EBAY
47
-2
SCHW
52
3
MDLZ
65
-2
NTAP
60
2
NSC
62
-5
VNO
57
-2
T
56
2
TRIP
66
5
BRK.B
42
-3
SYF
65
-6
CF
57
-3
SBUX
41
-3
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

TAK
Takeda Pharmaceutical

Last Price:
14.80
Seasonality Move:
-4.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Takeda Pharmaceutical Price Quote

$14.80

Takeda Pharmaceutical Key Stats

Sell
33
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$14.76 - $14.87
52-week range:
$12.58 - $16.06
Dividend yield:
4.13%
P/E ratio:
46.86
P/S ratio:
1.59
P/B ratio:
0.97%
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
-9.15%
Market cap:
$46.9B
Revenue:
$29.5B
EPS:
$0.31

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.08%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $5.4B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.5M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 1.21%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 0.97%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 2.03%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: -7.63% 0%
Revenue: 0.44% 15.89%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.07
Upside from Last Price: 15.34%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    187.9M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders